Rodrguez-Rodrguez et al. reported in their work that patients with RA who are carriers of this deletion presented significantly higher FMD values compared to other patients, implying that the CCR5 molecule may play a role in the development of ASCVD in RA [71]. Here, CCR5 is linked to rheumatoid arthritis.